Name | Temocaprilat |
---|---|
Synonyms |
(2S-(2a,6b(R*)))-6-((1-Carboxy-3-phenylpropyl)amino)tetrahydro-5-oxo-2-(2-thienyl)-1,4-thiazepine-4(5H)-acetic acid
[[[2S,6R]-6-[[(S)-1-Carboxy-3-phenylpropyl]amino]hexahydro-5-oxo-2-(2-thienyl)-1,4-thiazepin]-4-yl]acetic acid 1,4-Thiazepine-4(5H)-acetic acid, 6-[[(1S)-1-carboxy-3-phenylpropyl]amino]tetrahydro-5-oxo-2-(2-thienyl)-, (2S,6R)- (+)-[(2S,6R)-6-[[(S)-1-(Ethoxycarbonyl)-3-phenylpropyl]amino]-5-oxo-2-(2-thienyl)perhydro-1,4-thiazepin-4-yl]acetic acid Temocaprilat (2S,6R)-6-[[(1S)-1-Carboxy-3-phenylpropyl]amino]tetrahydro-5-oxo-2-(2-thienyl)-1,4-thiazepine-4(5H)-acetic Acid (2S)-2-{[(2S,6R)-4-(Carboxymethyl)-5-oxo-2-(2-thienyl)-1,4-thiazepan-6-yl]amino}-4-phenylbutanoic acid Temocapril Diacid (+)-(2S,6R)-6-(((1S)-1-carboxy-3-phenylpropyl)amino)tetrahydro-5-oxo-2-(2-thienyl)-1,4-thiazepine-4(5H)-acetic acid (2S)-2-{[(2S,6R)-4-(carboxymethyl)-5-oxo-2-(thiophen-2-yl)-1,4-thiazepan-6-yl]amino}-4-phenylbutanoic acid RS-5139 |
Description | Temocaprilat (Temocapril diacid) is an inhibitor of angiotensin-converting enzyme (ACE). Temocaprilat alleviates the inhibitory effect of high glucose on the proliferation of aortic endothelial cells. Temocaprilat has potential applications in hypertension and vascular inflammation[1][2][3][4]. |
---|---|
Related Catalog | |
In Vitro | Temocaprilat (1、10、100 和 1000 nM;72 h) 以剂量依赖性方式缓解了高糖 (22.2 mM) 介导的人主动脉内皮细胞 (HAECs) 增殖抑制。Temocaprilat 在 HAECs 中抑制高糖诱导的氧化应激[1]。 Temocaprilat (1 µM;10 min) 在 HAECs 中增加了蛋白激酶 C (PKC) 活性[1]。 Temocaprilat (0.1 µM) 通过降低 IL-6 mRNA 的稳定性抑制 IL-1β 诱导的 IL-6 表达[4]。 |
In Vivo | Temocaprilat (1 mg/kg/d;静脉注射;4 周) 在自发性高血压大鼠 (SHRs) 中,以时间依赖性方式显著降低了收缩压。Temocaprilat 改善了 Wistar-Kyoto (WKY) 小鼠和 SHR 小鼠的心肌纤维化及氧化应激[3]。 Animal Model: Six 10-week-old WKYs and SHRs and six 50-week-old (aging control) SHRs[3]. Dosage: 1 mg/kg/d. Administration: Intravenous injection; 4 weeks. Result: Reduced the expression levels of myocardial fibrosis, transforming growth factor-β1 (TGF-β1) mRNA and fibroblast growth factor-2 (FGF-2) mRNA in the left ventricle (LV). Weakened the expression levels of 8-isoprostane, p22phox mRNA, p47phox mRNA and gp91phox mRNA in LV. |
References |
Density | 1.4±0.1 g/cm3 |
---|---|
Boiling Point | 743.6±60.0 °C at 760 mmHg |
Melting Point | >230ºC (dec) |
Molecular Formula | C21H24N2O5S2 |
Molecular Weight | 448.556 |
Flash Point | 403.5±32.9 °C |
Exact Mass | 448.112671 |
PSA | 160.48000 |
LogP | 3.51 |
Vapour Pressure | 0.0±2.6 mmHg at 25°C |
Index of Refraction | 1.665 |
Storage condition | -20°C |
Precursor 10 | |
---|---|
DownStream 0 |